The efficiency frontier approach to economic evaluation of health-care interventions

Jaime J. Caro, Erik Nord, Uwe Siebert, Alistair Mcguire, Maurice Mcgregor, David Henry, Gérard De Pouvourville, Vincenzo Atella, Peter Kolominsky-Rabas

Research output: Contribution to journalArticleResearchpeer-review

72 Citations (Scopus)
11 Downloads (Pure)

Abstract

Background: IQWiG commissioned an international panel of experts to develop methods for the assessment of the relation of benefits to costs in the German statutory health-care system. Proposed methods: The panel recommended that IQWiG inform German decision makers of the net costs and value of additional benefits of an intervention in the context of relevant other interventions in that indication. To facilitate guidance regarding maximum reimbursement, this information is presented in an efficiency plot with costs on the horizontal axis and value of benefits on the vertical. The efficiency frontier links the interventions that are not dominated and provides guidance. A technology that places on the frontier or to the left is reasonably efficient, while one falling to the right requires further justification for reimbursement at that price. This information does not automatically give the maximum reimbursement, as other considerations may be relevant. Given that the estimates are for a specific indication, they do not address priority setting across the health-care system. Conclusion: This approach informs decision makers about efficiency of interventions, conforms to the mandate and is consistent with basic economic principles. Empirical testing of its feasibility and usefulness is required.

Original languageEnglish
Pages (from-to)1117-1127
Number of pages11
JournalHealth Economics
Volume19
Issue number10
DOIs
Publication statusPublished - Oct 2010
Externally publishedYes

Fingerprint

Cost-Benefit Analysis
Delivery of Health Care
Costs and Cost Analysis
Economics
Technology

Cite this

Caro, J. J., Nord, E., Siebert, U., Mcguire, A., Mcgregor, M., Henry, D., ... Kolominsky-Rabas, P. (2010). The efficiency frontier approach to economic evaluation of health-care interventions. Health Economics, 19(10), 1117-1127. https://doi.org/10.1002/hec.1629
Caro, Jaime J. ; Nord, Erik ; Siebert, Uwe ; Mcguire, Alistair ; Mcgregor, Maurice ; Henry, David ; De Pouvourville, Gérard ; Atella, Vincenzo ; Kolominsky-Rabas, Peter. / The efficiency frontier approach to economic evaluation of health-care interventions. In: Health Economics. 2010 ; Vol. 19, No. 10. pp. 1117-1127.
@article{edc20e50923b4be2b3d2aac8a1b5f391,
title = "The efficiency frontier approach to economic evaluation of health-care interventions",
abstract = "Background: IQWiG commissioned an international panel of experts to develop methods for the assessment of the relation of benefits to costs in the German statutory health-care system. Proposed methods: The panel recommended that IQWiG inform German decision makers of the net costs and value of additional benefits of an intervention in the context of relevant other interventions in that indication. To facilitate guidance regarding maximum reimbursement, this information is presented in an efficiency plot with costs on the horizontal axis and value of benefits on the vertical. The efficiency frontier links the interventions that are not dominated and provides guidance. A technology that places on the frontier or to the left is reasonably efficient, while one falling to the right requires further justification for reimbursement at that price. This information does not automatically give the maximum reimbursement, as other considerations may be relevant. Given that the estimates are for a specific indication, they do not address priority setting across the health-care system. Conclusion: This approach informs decision makers about efficiency of interventions, conforms to the mandate and is consistent with basic economic principles. Empirical testing of its feasibility and usefulness is required.",
author = "Caro, {Jaime J.} and Erik Nord and Uwe Siebert and Alistair Mcguire and Maurice Mcgregor and David Henry and {De Pouvourville}, G{\'e}rard and Vincenzo Atella and Peter Kolominsky-Rabas",
year = "2010",
month = "10",
doi = "10.1002/hec.1629",
language = "English",
volume = "19",
pages = "1117--1127",
journal = "Health Economics",
issn = "1057-9230",
publisher = "John Wiley & Sons",
number = "10",

}

Caro, JJ, Nord, E, Siebert, U, Mcguire, A, Mcgregor, M, Henry, D, De Pouvourville, G, Atella, V & Kolominsky-Rabas, P 2010, 'The efficiency frontier approach to economic evaluation of health-care interventions' Health Economics, vol. 19, no. 10, pp. 1117-1127. https://doi.org/10.1002/hec.1629

The efficiency frontier approach to economic evaluation of health-care interventions. / Caro, Jaime J.; Nord, Erik; Siebert, Uwe; Mcguire, Alistair; Mcgregor, Maurice; Henry, David; De Pouvourville, Gérard; Atella, Vincenzo; Kolominsky-Rabas, Peter.

In: Health Economics, Vol. 19, No. 10, 10.2010, p. 1117-1127.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The efficiency frontier approach to economic evaluation of health-care interventions

AU - Caro, Jaime J.

AU - Nord, Erik

AU - Siebert, Uwe

AU - Mcguire, Alistair

AU - Mcgregor, Maurice

AU - Henry, David

AU - De Pouvourville, Gérard

AU - Atella, Vincenzo

AU - Kolominsky-Rabas, Peter

PY - 2010/10

Y1 - 2010/10

N2 - Background: IQWiG commissioned an international panel of experts to develop methods for the assessment of the relation of benefits to costs in the German statutory health-care system. Proposed methods: The panel recommended that IQWiG inform German decision makers of the net costs and value of additional benefits of an intervention in the context of relevant other interventions in that indication. To facilitate guidance regarding maximum reimbursement, this information is presented in an efficiency plot with costs on the horizontal axis and value of benefits on the vertical. The efficiency frontier links the interventions that are not dominated and provides guidance. A technology that places on the frontier or to the left is reasonably efficient, while one falling to the right requires further justification for reimbursement at that price. This information does not automatically give the maximum reimbursement, as other considerations may be relevant. Given that the estimates are for a specific indication, they do not address priority setting across the health-care system. Conclusion: This approach informs decision makers about efficiency of interventions, conforms to the mandate and is consistent with basic economic principles. Empirical testing of its feasibility and usefulness is required.

AB - Background: IQWiG commissioned an international panel of experts to develop methods for the assessment of the relation of benefits to costs in the German statutory health-care system. Proposed methods: The panel recommended that IQWiG inform German decision makers of the net costs and value of additional benefits of an intervention in the context of relevant other interventions in that indication. To facilitate guidance regarding maximum reimbursement, this information is presented in an efficiency plot with costs on the horizontal axis and value of benefits on the vertical. The efficiency frontier links the interventions that are not dominated and provides guidance. A technology that places on the frontier or to the left is reasonably efficient, while one falling to the right requires further justification for reimbursement at that price. This information does not automatically give the maximum reimbursement, as other considerations may be relevant. Given that the estimates are for a specific indication, they do not address priority setting across the health-care system. Conclusion: This approach informs decision makers about efficiency of interventions, conforms to the mandate and is consistent with basic economic principles. Empirical testing of its feasibility and usefulness is required.

UR - http://www.scopus.com/inward/record.url?scp=77951080958&partnerID=8YFLogxK

U2 - 10.1002/hec.1629

DO - 10.1002/hec.1629

M3 - Article

VL - 19

SP - 1117

EP - 1127

JO - Health Economics

JF - Health Economics

SN - 1057-9230

IS - 10

ER -